Clinical Trials Directory

Trials / Unknown

UnknownNCT03091010

A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.

A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis A Randomized Controlled Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Study population: Patients attending the Out Patient Department and admitted to Institute of Liver and Biliary Sciences. Study design: Prospective randomized controlled trial Study period: One year- January 2017- December 2018 Sample size: 130 (65 cases in each group) Intervention: The subjects will be given Fecal Microbiota Transplantation through a NJ tube placed after admission to the hospital. Participants will be administered the processed fecal microbiota sample collected from a related or unrelated healthy donor for a period of 7 days. Monitoring and assessment: The recipient will be monitored every day after Fecal Microbiota Transplantation therapy. The recipient will undergo physical examination, complete blood counts, at baseline and a chest X ray, serum procalcitonin, CRP and Tumor Necrosis Factor alpha levels, Liver Function Tests, Kidney Function Tests, International Normalized Ratio and arterial ammonia, at day 0,4,7,14,28,90,180,270 and 365 from the start of therapy. Microbiota analysis of the donors will be done at baseline and the recipients will be done on day 0,7,28,90 \& 180.

Conditions

Interventions

TypeNameDescription
OTHERFecal Microbiota TransplantationFecal Microbiota Transplantation will be given 100mL of suspension. It will given for a period of 7 days
DRUGSteroidsOral steroids 40 mg (prednisolone) will be given for a period of 7 days in hospital followed by 3 weeks on OPD basis

Timeline

Start date
2017-04-08
Primary completion
2019-03-24
Completion
2020-06-30
First posted
2017-03-27
Last updated
2020-01-22

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03091010. Inclusion in this directory is not an endorsement.